BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Welcome to the 2nd mRNA Analytical Development Summit: Trailbl
 azing Advanced Analytics for Superior mRNA Therapeutics and Vaccines\n\nU
 niting 80+ Senior Scientists\, Directors\, and Heads of Analytical Develo
 pment\, Quality Control\, CMC and Regulatory - join us in Boston alongsid
 e pioneering speakers from innovative biopharma and KOLs of academia.\n\n
 Avoid missing out on networking with those shaping the landscape of novel
  and emerging analytical tools and technologies for mRNA-based therapeuti
 cs and vaccines. Meet your community face-to-face in 2023 to hear how the
 y address the major challenges facing the industry:\n\nExplore Emerging T
 echnologies and Novel Analytical Approaches for mRNA Therapeutics and Vac
 cinesWith mRNA therapeutics and vaccines disrupting the industry\, hear f
 rom the likes of Beam Therapeutics\, Merck\, and Pfizer on where innovati
 on is expected to come from and discuss the opportunities emerging analyt
 ical and biological technologies offer over traditional methods\n\nImprov
 e Chemical-Based Assays and Nanoformulation for RNA-based Vaccines and Th
 erapeuticsThis meeting will shine the spotlight on novel analytical techn
 iques for RNA-based therapeutics and vaccines and emerge into innovating 
 nanoformulation as well as unravel the interaction between the drug produ
 ct and cell with research institutes and companies including GSK\, MIT\, 
 and CureVac\n\nUnderstand Regulatory Expectations and Establish Clinical 
 Success with Emerging Assays and Analytical ToolsExplore the FDA's person
 al perspective of common mistakes observed in regulatory submissions for 
 analytical method validation and real-world examples of physicochemical m
 ethods previously submitted for biological drug testing\n\nOvercome Scale
 -Up Challenges and Emerge into Bioanalytical ImmunologyDiscuss how to ove
 rcome analytical and scale-up challenges of emerging RNA modalities and h
 ow to find the balance between high immunoreactivity and low toxicity wit
 h insights from Ziphius Vaccines\, BioNTech\, and Replicate Bioscience\n\
 nDelve into Advancements in Innovative Characterization Tools for mRNA-Ba
 sed Therapeutics and VaccinesDelve into pioneering approaches to characte
 rize and purify RNA in lipid nanoparticles intended for base editing with
  Beam Therapeutics\, Arcturus Therapeutics\, and Seqirus\n\nJoin us Febru
 ary 14-16\, 202 in Boston\, MA!\n
DTEND:20230216T190000
DTSTAMP:20260416T135329Z
DTSTART:20230214T080000
LOCATION:Hyatt Regency Boston\, One Ave. de Lafayette\, Boston\, Massachus
 etts\, 02111\,
SEQUENCE:0
SUMMARY:Welcome to the 2nd mRNA Analytical Development Summit: Trailblazin
 g Advanced Analytics for Superior mRNA Therapeutics and Vaccines\nUniting
  80+ Sen...
UID:f04e394d-e464-453f-bb39-4e758fb453e2
END:VEVENT
END:VCALENDAR